JPS57179178A - 4-oxo-pgi2 derivative, manufacture and use - Google Patents

4-oxo-pgi2 derivative, manufacture and use

Info

Publication number
JPS57179178A
JPS57179178A JP57061195A JP6119582A JPS57179178A JP S57179178 A JPS57179178 A JP S57179178A JP 57061195 A JP57061195 A JP 57061195A JP 6119582 A JP6119582 A JP 6119582A JP S57179178 A JPS57179178 A JP S57179178A
Authority
JP
Japan
Prior art keywords
oxo
manufacture
pgi2 derivative
pgi2
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57061195A
Other languages
English (en)
Inventor
Garamuboshiyu Geeza
Shimonidesu Buirumoshiyu
Ibuanitsuchiyu Yoojiefu
Seekeri Ishiyutobuaan
Keekeshi Kurisuchina
Kobuaachiyu Gaaboru
Shiyutatsudogeru Ishiyutobuaan
Kerumetsui Peeteru
Horubuaato Kaarori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of JPS57179178A publication Critical patent/JPS57179178A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
JP57061195A 1981-04-14 1982-04-14 4-oxo-pgi2 derivative, manufacture and use Pending JPS57179178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU81966A HU184949B (en) 1981-04-14 1981-04-14 Process for preparing 4-oxo-pgi down 2 and analogues thereof

Publications (1)

Publication Number Publication Date
JPS57179178A true JPS57179178A (en) 1982-11-04

Family

ID=10952245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57061195A Pending JPS57179178A (en) 1981-04-14 1982-04-14 4-oxo-pgi2 derivative, manufacture and use

Country Status (14)

Country Link
US (1) US4438132A (ja)
EP (1) EP0063338B1 (ja)
JP (1) JPS57179178A (ja)
AT (1) ATA139182A (ja)
CS (1) CS228923B2 (ja)
DD (1) DD202559A5 (ja)
DE (1) DE3262285D1 (ja)
DK (1) DK165382A (ja)
FI (1) FI821282L (ja)
GR (1) GR76128B (ja)
HU (1) HU184949B (ja)
IL (1) IL65491A (ja)
PL (1) PL235963A1 (ja)
SU (1) SU1128834A3 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184948B (en) * 1981-04-14 1984-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126744A (en) * 1977-12-05 1978-11-21 The Upjohn Company 4-Oxo-PGI1 compounds
JPS54115368A (en) * 1978-03-01 1979-09-07 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition containing it as active constituent

Also Published As

Publication number Publication date
FI821282A0 (fi) 1982-04-13
ATA139182A (de) 1986-03-15
DD202559A5 (de) 1983-09-21
HU184949B (en) 1984-11-28
DE3262285D1 (en) 1985-03-28
EP0063338A1 (de) 1982-10-27
DK165382A (da) 1982-10-15
IL65491A (en) 1986-01-31
CS228923B2 (en) 1984-05-14
IL65491A0 (en) 1982-07-30
FI821282L (fi) 1982-10-15
SU1128834A3 (ru) 1984-12-07
EP0063338B1 (de) 1985-02-13
GR76128B (ja) 1984-08-03
US4438132A (en) 1984-03-20
PL235963A1 (en) 1983-07-04

Similar Documents

Publication Publication Date Title
DE3171325D1 (en) Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
DE3266288D1 (en) Tetrahydrophthalimides, and their production and use
DE3262455D1 (en) Diphenoxypropane derivatives, their production and use
JPS5716868A (en) 1-hydroxyethyl-azole derivative,manufacture and use
DE3265157D1 (en) Ethyleneglycol derivatives, their production and use
JPS57120586A (en) Dibenzazepine derivative, manufacture and use
JPS5756478A (en) Triazinylaminotriazines, manufacture and use
DE3273986D1 (en) Homobrassinolide, and its production and use
JPS57159784A (en) Pyridine compound, manufacture and use
JPS5748993A (en) N-phosphonylcarbonyl-carbamates, manufacture and use
JPS57165307A (en) Vermicides, manufacture and use
EG15753A (en) Pest-combating agents,their prepotion and use
JPS57175135A (en) 4-halogenostilbene derivative and manufacture
DE3261522D1 (en) Dressings, manufacture and use
JPS57192373A (en) Halogenopyrimidines, manufacture and use
JPS57197296A (en) Novel aminoacridine-glycoside derivative, manufacture and medicine
JPS57122077A (en) Dihydropyranes, manufacture and use
CS914282A2 (en) Hydraulicky valec, zejmena dulni vzpera s kombinovanou funkci
DE3267439D1 (en) Trifluoromethanesulfonanilides, and their production and use
JPS5753471A (en) Triazolylpropenol derivative, manufacture and use
JPS5795968A (en) Trichloromethylquinoxalines, manufacture and use
JPS57179178A (en) 4-oxo-pgi2 derivative, manufacture and use
JPS57188530A (en) 1,1-diphenylalk-1-ene and manufacture
JPS57179198A (en) 3-oxo-17 alpha-ethynyl-17 beta-trifluoroacetoxy- gonane derivatives and manufacture
JPS57188593A (en) Novel dioxazabicyclo derivative, manufacture and drug